Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 17  •  04:00PM ET
2.35
Dollar change
-0.04
Percentage change
-1.67
%
Index- P/E- EPS (ttm)-0.79 Insider Own43.95% Shs Outstand56.31M Perf Week-0.42%
Market Cap132.40M Forward P/E3.51 EPS next Y0.67 Insider Trans-0.88% Shs Float31.58M Perf Month-2.08%
Enterprise Value87.13M PEG- EPS next Q- Inst Own15.11% Short Float2.98% Perf Quarter-3.69%
Income-43.84M P/S4.52 EPS this Y92.13% Inst Trans1.33% Short Ratio3.10 Perf Half Y23.04%
Sales29.32M P/B4.99 EPS next Y770.00% ROA-46.31% Short Interest0.94M Perf YTD0.86%
Book/sh0.47 P/C2.72 EPS next 5Y- ROE-95.29% 52W High3.22 -27.02% Perf Year188.34%
Cash/sh0.86 P/FCF- EPS past 3/5Y24.13% 17.67% ROIC-156.86% 52W Low0.51 365.16% Perf 3Y37.43%
Dividend Est.- EV/EBITDA- Sales past 3/5Y107.42% 8.59% Gross Margin- Volatility3.53% 4.83% Perf 5Y-88.93%
Dividend TTM- EV/Sales2.97 EPS Y/Y TTM-1076.54% Oper. Margin-192.13% ATR (14)0.11 Perf 10Y-
Dividend Ex-Date- Quick Ratio3.83 Sales Y/Y TTM-67.38% Profit Margin-149.52% RSI (14)49.74 Recom3.00
Dividend Gr. 3/5Y- - Current Ratio3.83 EPS Q/Q58.59% SMA200.62% Beta1.43 Target Price4.00
Payout- Debt/Eq0.13 Sales Q/Q-61.02% SMA50-0.36% Rel Volume0.93 Prev Close2.39
Employees32 LT Debt/Eq0.05 EarningsNov 13 AMC SMA2007.22% Avg Volume304.15K Price2.35
IPONov 02, 2017 Option/ShortYes / Yes EPS/Sales Surpr.48.00% - Trades Volume283,074 Change-1.67%
Date Action Analyst Rating Change Price Target Change
Dec-20-24Downgrade Evercore ISI Outperform → In-line $5
Sep-23-22Upgrade Evercore ISI In-line → Outperform $2 → $8
Oct-01-21Downgrade Oppenheimer Outperform → Perform
Jan-22-21Reiterated H.C. Wainwright Buy $33 → $40
Dec-16-20Initiated Berenberg Buy $47
Sep-29-20Initiated Evercore ISI Outperform
Nov-05-19Reiterated H.C. Wainwright Buy $28 → $35
Sep-09-19Initiated Janney Buy
Feb-09-18Initiated Cantor Fitzgerald Overweight $27
Nov-27-17Initiated Stifel Buy $26
Feb-04-26 08:31AM
Dec-19-25 08:00AM
Nov-28-25 08:00AM
Nov-13-25 04:05PM
Nov-04-25 04:05PM
02:00AM Loading…
Oct-21-25 02:00AM
Oct-14-25 08:00AM
Oct-10-25 10:00AM
Oct-08-25 11:23AM
Aug-19-25 09:35AM
Aug-13-25 03:11AM
Aug-12-25 04:01PM
Aug-05-25 04:05PM
Jul-08-25 10:31AM
Jul-04-25 08:35AM
08:34AM Loading…
Jul-02-25 08:34AM
Jul-01-25 11:55AM
10:05AM
Jun-30-25 10:40AM
May-29-25 01:15PM
11:18AM
May-28-25 07:00AM
07:00AM
May-13-25 05:10PM
04:01PM
May-12-25 09:53AM
May-09-25 08:20AM
May-08-25 05:55PM
May-07-25 05:25PM
May-05-25 08:00AM
04:01PM Loading…
Apr-28-25 04:01PM
Mar-28-25 07:10AM
03:03AM
Mar-27-25 08:31PM
05:20PM
04:01PM
Mar-18-25 08:00AM
Feb-25-25 10:15AM
07:00AM
Jan-15-25 12:00PM
Jan-10-25 07:00AM
Dec-16-24 06:34PM
Nov-18-24 12:09PM
Nov-14-24 05:35PM
04:05PM
Nov-13-24 07:29AM
Nov-07-24 04:05PM
Oct-30-24 08:45AM
Oct-29-24 04:05PM
Oct-16-24 04:05PM
Oct-02-24 04:30PM
Sep-04-24 04:05PM
Aug-06-24 07:51AM
Aug-05-24 08:59PM
05:35PM
04:01PM
Jul-29-24 04:05PM
Jul-08-24 03:07PM
Jul-03-24 01:05PM
Jun-03-24 04:05PM
May-16-24 04:05PM
May-15-24 08:55PM
04:05PM
May-08-24 08:00AM
May-01-24 04:07PM
Apr-16-24 11:52AM
Mar-15-24 12:51PM
Mar-14-24 06:33AM
Mar-13-24 05:10PM
04:01PM
Mar-06-24 08:05AM
Feb-28-24 08:05AM
Feb-26-24 08:05AM
Feb-05-24 11:27PM
Jan-31-24 04:05PM
Jan-29-24 04:07AM
Jan-25-24 04:40AM
Jan-05-24 08:05AM
Jan-02-24 08:05AM
Nov-14-23 09:02AM
Nov-13-23 04:05PM
Nov-06-23 08:05AM
Nov-01-23 04:05PM
08:05AM
Oct-31-23 04:05PM
Oct-18-23 12:00PM
Sep-29-23 04:05PM
Sep-20-23 04:05PM
Sep-16-23 01:01PM
Sep-12-23 08:00AM
Sep-06-23 08:05AM
Aug-31-23 04:05PM
Aug-29-23 12:00PM
Aug-22-23 05:45PM
Aug-13-23 05:24AM
Aug-11-23 06:32AM
Aug-10-23 06:05PM
04:05PM
Aug-03-23 08:05AM
Jul-31-23 08:05AM
Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on identifying, developing, and commercializing treatments involving bacterial infections, including multi-drug resistant bacterial infections, and rare diseases Its pipeline product candidates include Tebipenem HBr, SPR720, and SPR206. The company was founded by Ankit A. Mahadevia and Laurence Rahme in April 2013 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rajavelu EstherSee RemarksFeb 06 '26Sale2.3687,917207,4841,012,091Feb 09 09:31 PM
Keutzer TimothyChief Operating OfficerFeb 06 '26Sale2.3618,65244,019742,506Feb 09 09:09 PM
Keutzer TimothyChief Operating OfficerFeb 03 '26Sale2.1424,22451,839764,629Feb 05 06:30 AM
Keutzer TimothyChief Operating OfficerFeb 02 '26Sale2.2018,89141,560788,853Feb 05 06:30 AM
Keutzer TimothyChief Operating OfficerFeb 04 '26Sale2.243,4717,775761,158Feb 05 06:30 AM
Rajavelu EstherSee RemarksFeb 02 '26Sale2.2018,44240,5721,100,008Feb 04 09:44 PM
Rajavelu EstherSee RemarksNov 07 '25Sale2.3740,27095,440869,450Nov 12 08:44 PM
Mahadevia AnkitDirectorAug 28 '25Sale1.976,57212,947703,294Sep 03 06:04 AM
Keutzer TimothyChief Operating OfficerAug 28 '25Sale1.971,6953,339739,744Sep 03 06:02 AM
Last Close
Feb 17  •  04:00PM ET
25.52
Dollar change
-0.44
Percentage change
-1.69
%
NOG Northern Oil and Gas Inc daily Stock Chart
IndexRUT P/E14.39 EPS (ttm)1.77 Insider Own3.03% Shs Outstand97.60M Perf Week-1.39%
Market Cap2.49B Forward P/E9.27 EPS next Y2.75 Insider Trans0.85% Shs Float94.65M Perf Month13.12%
Enterprise Value4.81B PEG- EPS next Q0.79 Inst Own112.02% Short Float19.94% Perf Quarter15.48%
Income181.19M P/S1.14 EPS this Y-15.63% Inst Trans-3.17% Short Ratio8.74 Perf Half Y4.85%
Sales2.19B P/B1.11 EPS next Y-37.95% ROA3.44% Short Interest18.87M Perf YTD18.86%
Book/sh23.00 P/C78.70 EPS next 5Y-16.49% ROE7.95% 52W High36.16 -29.42% Perf Year-27.31%
Cash/sh0.32 P/FCF- EPS past 3/5Y- - ROIC3.95% 52W Low19.88 28.37% Perf 3Y-20.10%
Dividend Est.1.79 (7.00%) EV/EBITDA3.19 Sales past 3/5Y30.43% 29.19% Gross Margin34.86% Volatility4.57% 3.84% Perf 5Y114.09%
Dividend TTM1.80 (7.05%) EV/Sales2.19 EPS Y/Y TTM-78.38% Oper. Margin31.57% ATR (14)1.06 Perf 10Y-16.05%
Dividend Ex-DateDec 30, 2025 Quick Ratio1.10 Sales Y/Y TTM1.51% Profit Margin8.26% RSI (14)57.20 Recom2.00
Dividend Gr. 3/5Y121.95% - Current Ratio1.10 EPS Q/Q-144.85% SMA203.64% Beta0.98 Target Price30.58
Payout31.92% Debt/Eq1.05 Sales Q/Q-5.75% SMA509.75% Rel Volume0.75 Prev Close25.96
Employees49 LT Debt/Eq1.05 EarningsFeb 25 AMC SMA2001.52% Avg Volume2.16M Price25.52
IPOJan 10, 2007 Option/ShortYes / Yes EPS/Sales Surpr.18.24% 7.53% Trades Volume1,625,093 Change-1.69%
Date Action Analyst Rating Change Price Target Change
Aug-25-25Initiated William Blair Outperform
Aug-18-25Downgrade Morgan Stanley Equal-Weight → Underweight $27
Feb-21-25Downgrade CapitalOne Overweight → Equal Weight
Dec-16-24Downgrade Mizuho Outperform → Neutral $47
Nov-20-24Downgrade RBC Capital Mkts Outperform → Sector Perform $43 → $45
Oct-03-24Resumed Jefferies Buy $53
Sep-19-24Initiated Mizuho Outperform $47
Jan-05-24Initiated Morgan Stanley Equal-Weight $40
Jan-05-24Downgrade BofA Securities Buy → Underperform $39
Dec-14-23Downgrade Johnson Rice Buy → Accumulate
Feb-10-26 04:10PM
Feb-02-26 09:28PM
Jan-20-26 05:09PM
Jan-15-26 03:58PM
Dec-17-25 01:07PM
07:00AM Loading…
07:00AM
Dec-09-25 07:55AM
Dec-08-25 07:00AM
07:00AM
Dec-03-25 01:13PM
Nov-10-25 08:20AM
Nov-08-25 02:06AM
Nov-06-25 06:15PM
05:16PM
04:05PM
06:15PM Loading…
Nov-05-25 06:15PM
04:10PM
Nov-04-25 01:37PM
12:20PM
11:32AM
10:54AM
08:38AM
Nov-03-25 06:00PM
Oct-31-25 04:48PM
Oct-30-25 10:00AM
Oct-29-25 05:15PM
Oct-21-25 04:05PM
Oct-09-25 04:05PM
Oct-05-25 09:26PM
Sep-22-25 05:23PM
08:22AM Loading…
08:22AM
Sep-12-25 09:10AM
Sep-03-25 11:30AM
Aug-29-25 12:26AM
Aug-25-25 04:15PM
Aug-20-25 11:53PM
Aug-18-25 08:59AM
Aug-17-25 11:56PM
Aug-13-25 01:48PM
Aug-05-25 08:03AM
Aug-04-25 09:30AM
Aug-02-25 03:10AM
Aug-01-25 07:30AM
Jul-31-25 06:10PM
05:05PM
04:15PM
09:24AM
Jul-30-25 09:39AM
02:29AM
Jul-28-25 11:11AM
10:00AM
08:38AM
Jul-24-25 10:00AM
07:30AM
Jul-23-25 08:03AM
Jul-21-25 10:08AM
05:21AM
Jul-15-25 04:05PM
10:24AM
Jul-14-25 08:06AM
Jul-07-25 10:18AM
Jun-17-25 04:15PM
Jun-13-25 10:31AM
Jun-12-25 10:45PM
04:02PM
Jun-06-25 11:30AM
Jun-05-25 11:31AM
May-29-25 11:30AM
May-15-25 08:36AM
May-14-25 11:11AM
May-02-25 09:30AM
07:08AM
May-01-25 11:30PM
03:11AM
02:19AM
Apr-30-25 05:00PM
03:34PM
08:36AM
07:00AM
Apr-29-25 05:45PM
04:45PM
04:05PM
Apr-28-25 11:46PM
Apr-23-25 05:28PM
10:01AM
Apr-22-25 10:00AM
Apr-21-25 08:55AM
Apr-18-25 03:28PM
Apr-16-25 04:10PM
Apr-14-25 03:52PM
Apr-10-25 04:15PM
Apr-03-25 06:17AM
Mar-25-25 12:47PM
Mar-21-25 11:30AM
Mar-11-25 04:15PM
Mar-06-25 08:00PM
Mar-04-25 06:22PM
Mar-03-25 06:00AM
Mar-01-25 10:15AM
Feb-21-25 02:08AM
Northern Oil & Gas, Inc. engages in the acquisition, exploration, development, and production of crude oil and natural gas properties. It focuses on the Bakken and Three Forks formation within the Williston Basin in North Dakota and Montana. The company was founded by Michael Lewis Reger in 2006 and is headquartered in Minnetonka, MN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
EASLEY ROY ERNESTDirectorDec 10 '25Buy24.4615,000366,93373,132Dec 12 04:59 PM
EASLEY ROY ERNESTDirectorDec 11 '25Buy23.3810,000233,83783,132Dec 12 04:59 PM
Allen Chad WOfficerJun 02 '25Proposed Sale27.226,000163,320Jun 02 02:36 PM
Dirlam Adam A.OfficerJun 02 '25Proposed Sale27.0017,160463,320Jun 02 02:27 PM
O'GRADY NICHOLAS L.CEOMar 07 '25Buy27.481,00027,480226,189Mar 10 09:43 AM
Lasher Stuart G.DirectorMar 04 '25Buy27.6220,000552,40040,000Mar 05 12:55 PM
Akradi BahramDirectorMar 04 '25Buy28.0340,0001,121,3601,662,016Mar 04 05:25 PM
Allen Chad WOfficerMar 03 '25Proposed Sale28.006,000168,000Mar 03 04:30 PM
Dirlam Adam A.OfficerMar 03 '25Proposed Sale10.9417,160187,687Mar 03 04:24 PM
O'GRADY NICHOLAS L.CEOMar 03 '25Buy28.591,50042,884225,189Mar 03 04:12 PM
Last Close
Feb 17  •  04:00PM ET
2.50
Dollar change
+0.03
Percentage change
1.21
%
UTSI UTStarcom Holdings Corp daily Stock Chart
Index- P/E- EPS (ttm)-0.66 Insider Own63.90% Shs Outstand8.88M Perf Week-3.85%
Market Cap23.67M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float3.42M Perf Month0.00%
Enterprise Value-22.43M PEG- EPS next Q- Inst Own1.28% Short Float0.25% Perf Quarter1.02%
Income-6.07M P/S2.42 EPS this Y- Inst Trans-1.84% Short Ratio1.61 Perf Half Y4.08%
Sales9.79M P/B0.56 EPS next Y- ROA-9.02% Short Interest0.01M Perf YTD-1.57%
Book/sh4.46 P/C0.50 EPS next 5Y- ROE-13.41% 52W High2.94 -14.97% Perf Year-3.85%
Cash/sh4.99 P/FCF- EPS past 3/5Y9.64% -1.64% ROIC-14.38% 52W Low1.84 35.87% Perf 3Y-45.30%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-11.92% -30.19% Gross Margin19.83% Volatility2.42% 3.59% Perf 5Y-71.46%
Dividend TTM- EV/Sales-2.29 EPS Y/Y TTM-50.58% Oper. Margin-80.51% ATR (14)0.11 Perf 10Y-70.66%
Dividend Ex-Date- Quick Ratio2.88 Sales Y/Y TTM-34.53% Profit Margin-62.02% RSI (14)51.02 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio2.99 EPS Q/Q-263.69% SMA200.57% Beta-0.17 Target Price10.00
Payout- Debt/Eq0.03 Sales Q/Q11.45% SMA502.02% Rel Volume0.23 Prev Close2.47
Employees219 LT Debt/Eq0.00 EarningsAug 29 BMO SMA2000.91% Avg Volume5.32K Price2.50
IPOMar 03, 2000 Option/ShortNo / Yes EPS/Sales Surpr.- - Trades Volume1,209 Change1.21%
Date Action Analyst Rating Change Price Target Change
Aug-31-15Initiated Northland Capital Outperform $2.50
Sep-17-10Initiated Auriga U.S.A Buy $3
Feb-27-09Reiterated Jefferies & Co Underperform $1.50 → $0.75
Feb-27-09Downgrade BWS Financial Buy → Hold
Sep-18-08Upgrade BWS Financial Hold → Buy
Aug-07-08Downgrade Jefferies & Co Hold → Underperform $4.50 → $3.60
Aug-07-08Downgrade BWS Financial Buy → Hold $6 → $4.50
Dec-10-07Reiterated BWS Financial Buy $10 → $6
Jun-04-07Reiterated BWS Financial Buy $15 → $10
Jan-08-26 03:36AM
Aug-29-25 06:15AM
Apr-25-25 04:42PM
Mar-24-25 06:27AM
Jan-22-25 04:15AM
06:23AM Loading…
Sep-05-24 06:23AM
Apr-29-24 04:50PM
Mar-26-24 06:16AM
Mar-22-24 06:18AM
Aug-30-23 06:48AM
Apr-27-23 04:40PM
Mar-27-23 06:16AM
Mar-24-23 08:06AM
Jan-04-23 06:00AM
Sep-02-22 06:06AM
06:00AM Loading…
06:00AM
Jul-29-22 08:55AM
Jul-15-22 06:00AM
Jun-30-22 06:00AM
Jun-28-22 06:00AM
May-27-22 09:50AM
May-18-22 06:00AM
May-11-22 06:00PM
Apr-26-22 04:05PM
Mar-24-22 06:54AM
Jan-28-22 07:30AM
Jan-04-22 05:33AM
Nov-19-21 06:00AM
Sep-16-21 06:00AM
Aug-13-21 06:00AM
06:00AM Loading…
06:00AM
Jun-29-21 10:01AM
May-24-21 05:30AM
Apr-21-21 09:31AM
Mar-30-21 09:13AM
Mar-25-21 07:52AM
Feb-08-21 08:30AM
Jan-11-21 03:15PM
06:00AM
Dec-31-20 06:00AM
Dec-28-20 06:00AM
Dec-11-20 06:54AM
Nov-06-20 06:00AM
Oct-30-20 05:00PM
Sep-29-20 05:50AM
Sep-01-20 08:40AM
Aug-31-20 06:00AM
May-20-20 06:00AM
Apr-29-20 08:00AM
Apr-28-20 05:00PM
Apr-10-20 10:37AM
Mar-27-20 06:00AM
Mar-16-20 06:00AM
Nov-27-19 12:11AM
Nov-15-19 08:25AM
Nov-08-19 07:30AM
06:00AM
Nov-01-19 10:30AM
06:40AM
06:00AM
Oct-31-19 08:58AM
Oct-30-19 09:18AM
Oct-25-19 07:45PM
Oct-15-19 11:08AM
Oct-01-19 08:07AM
Sep-27-19 09:02AM
Sep-18-19 08:40AM
Sep-17-19 08:44AM
Aug-23-19 08:24AM
Aug-20-19 07:55PM
Aug-13-19 05:35PM
04:15PM
Aug-05-19 06:00AM
Aug-02-19 09:37AM
Jul-17-19 10:29PM
May-23-19 07:01PM
May-10-19 09:37AM
07:45AM
06:36AM
06:30AM
May-03-19 10:30AM
06:00AM
Apr-17-19 06:00PM
Mar-22-19 04:09PM
Mar-15-19 06:20AM
06:00AM
Mar-08-19 06:00AM
Feb-13-19 06:00AM
Feb-10-19 04:42AM
Jan-21-19 06:00AM
Jan-14-19 06:00AM
Nov-09-18 11:27AM
06:07AM
06:00AM
05:00AM
Nov-05-18 06:00AM
Sep-12-18 06:00AM
Sep-11-18 08:21AM
Aug-15-18 09:35PM
Aug-03-18 06:11AM
UTStarcom Holdings Corp. is a telecom infrastructure company, which develops technology for cloud-based services, mobile, streaming, and other applications. It operates through the following segments: Equipment, and Services. The Equipment segment focuses on equipment sales including network infrastructure and application products, which include broadband products, wireless infrastructure technologies. The Services segment provides services and support for equipment products and also the new operational support segment. The company was founded in 1991 and is headquartered in Hangzhou, China.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Shao SeanDirectorSep 30 '25Proposed Sale2.483,0007,440Sep 29 06:54 AM
Shao SeanDirectorSep 09 '25Proposed Sale2.403,1777,625Sep 29 06:22 AM
Last Close
Feb 17  •  04:00PM ET
0.9500
Dollar change
+0.0300
Percentage change
3.26
%
DSS DSS Inc daily Stock Chart
Index- P/E- EPS (ttm)-5.68 Insider Own68.35% Shs Outstand9.09M Perf Week4.40%
Market Cap9.49M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float3.16M Perf Month-9.52%
Enterprise Value69.29M PEG- EPS next Q-0.38 Inst Own1.59% Short Float2.27% Perf Quarter-16.67%
Income-42.09M P/S0.43 EPS this Y- Inst Trans2.49% Short Ratio0.74 Perf Half Y13.77%
Sales22.05M P/B0.61 EPS next Y- ROA-35.85% Short Interest0.07M Perf YTD2.39%
Book/sh1.56 P/C1.08 EPS next 5Y44.86% ROE-126.92% 52W High1.89 -49.87% Perf Year0.00%
Cash/sh0.88 P/FCF- EPS past 3/5Y21.60% 37.21% ROIC-161.74% 52W Low0.72 31.94% Perf 3Y-79.39%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-1.98% 4.20% Gross Margin-4.45% Volatility5.12% 12.71% Perf 5Y-98.85%
Dividend TTM- EV/Sales3.14 EPS Y/Y TTM9.40% Oper. Margin-188.13% ATR (14)0.12 Perf 10Y-99.70%
Dividend Ex-Date- Quick Ratio0.26 Sales Y/Y TTM6.54% Profit Margin-190.91% RSI (14)46.88 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio0.32 EPS Q/Q66.19% SMA20-7.33% Beta1.30 Target Price3.00
Payout- Debt/Eq3.99 Sales Q/Q14.16% SMA50-5.37% Rel Volume0.45 Prev Close0.92
Employees100 LT Debt/Eq0.83 EarningsOct 27 SMA200-10.41% Avg Volume96.46K Price0.95
IPOApr 08, 1994 Option/ShortNo / Yes EPS/Sales Surpr.- - Trades Volume43,839 Change3.26%
Date Action Analyst Rating Change Price Target Change
Jun-24-20Initiated Aegis Capital Buy $14
Jul-22-13Initiated Dawson James Buy $4
Feb-05-26 09:45AM
Feb-04-26 08:35AM
Feb-03-26 08:17PM
Jun-24-25 08:30AM
May-22-25 08:31AM
08:30AM Loading…
Apr-24-25 08:30AM
Feb-26-25 08:30AM
Feb-03-25 08:50AM
Sep-16-24 04:26PM
Sep-10-24 09:00AM
Aug-26-24 04:08PM
Jan-30-24 08:05AM
Jan-04-24 08:15AM
Dec-22-23 04:30PM
Nov-28-23 08:10AM
01:57PM Loading…
Nov-15-23 01:57PM
Nov-14-23 08:00AM
Nov-08-23 08:31AM
Oct-26-23 05:25PM
Oct-23-23 08:25AM
Oct-12-23 08:25AM
Sep-06-23 08:40AM
Aug-29-23 05:40AM
Jul-31-23 08:15AM
Jul-27-23 09:00AM
Jul-12-23 09:00AM
Jul-05-23 08:15AM
Jun-30-23 09:34AM
Jun-27-23 09:15AM
Jun-26-23 08:20AM
07:00AM Loading…
Jun-13-23 07:00AM
May-17-23 11:07AM
May-16-23 09:00AM
May-01-23 08:25AM
Apr-19-23 09:08AM
Apr-18-23 07:00AM
Apr-17-23 10:00AM
Apr-11-23 09:10AM
Mar-27-23 09:00AM
Mar-22-23 08:05AM
Mar-13-23 09:25AM
Mar-07-23 09:25AM
Mar-02-23 08:30AM
Nov-17-22 10:05AM
Oct-19-22 08:00AM
Sep-22-22 09:15AM
Aug-30-22 04:45PM
Jul-26-22 08:00AM
Jul-21-22 05:00PM
Jul-13-22 08:00AM
Jun-28-22 08:00AM
Jun-07-22 07:00AM
May-19-22 11:10AM
May-06-22 08:30AM
Apr-07-22 10:15AM
Mar-03-22 08:00AM
Feb-28-22 05:15PM
08:00AM
Feb-22-22 05:00PM
Jan-25-22 04:30PM
Jan-20-22 08:45AM
Jan-19-22 03:57PM
12:13PM
Jan-12-22 08:30AM
Jan-11-22 10:00AM
Jan-10-22 08:30AM
Jan-03-22 11:04AM
Dec-22-21 07:30AM
Dec-20-21 10:10AM
Dec-15-21 07:30AM
Dec-07-21 07:30AM
07:00AM
Dec-01-21 05:15AM
Nov-30-21 07:30AM
Nov-04-21 09:00AM
Oct-28-21 08:00AM
Oct-20-21 08:00AM
Oct-05-21 08:00AM
Sep-20-21 07:30AM
Sep-13-21 09:32AM
Sep-09-21 07:00AM
Sep-08-21 07:00AM
Sep-07-21 08:00AM
Sep-02-21 06:25AM
Aug-23-21 01:52PM
09:00AM
Aug-17-21 08:30AM
Aug-02-21 09:45AM
Jul-27-21 08:00AM
Jul-12-21 08:00AM
Jul-06-21 08:30AM
Jun-30-21 08:30AM
Jun-24-21 09:10AM
Jun-17-21 10:00AM
09:46AM
Jun-16-21 09:00AM
Jun-15-21 08:54AM
Jun-14-21 08:08PM
May-24-21 09:31AM
May-20-21 12:15PM
DSS, Inc. engages in the development and distribution of paper products designed to protect valuable information from unauthorized scanning, copying, and digital imaging. It operates through the following segments: Product Packaging, Commercial Lending, Biotechnology, Direct Marketing, and Securities and Investment Management. The Product Packaging segment operates in the paper board folding carton, smart packaging, and document security printing markets. The Commercial Lending segment provides commercial loans and on acquiring equity positions in undervalued commercial bank(s), bank holding companies and non-banking licensed financial companies operating in the United States, Southeast Asia, Taiwan, Japan, and South Korea. The Biotechnology segment invests in or acquires companies in the bio-health and bio-medical fields, including businesses focused on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune related diseases. The Direct Marketing segment provides services to assist companies in the emerging growth big business model of peer-to-peer decentralized sharing marketplaces. The Securities and Investment Management segment develops and acquires assets and investments in the securities trading and funds management arena and to pursue, among other product and service lines, real estate investment funds, broker dealers and mutual funds management. The company was founded in May 1984 and is headquartered in West Henrietta, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DSS, INC.10% OwnerMay 22 '25Sale0.55115,60063,476590,424Jan 06 05:25 PM
DSS, INC.10% OwnerMay 27 '25Sale0.5445,40024,530545,024Jan 06 05:25 PM
DSS, INC.10% OwnerMay 22 '25Sale0.55115,60063,47645,400May 27 04:35 PM
DSS, INC.10% OwnerMay 27 '25Sale0.5445,40024,5300May 27 04:35 PM
DSS, INC.10% OwnerApr 04 '25Sale0.95890,800845,013161,100Apr 07 09:59 PM
DSS, INC.10% OwnerMar 21 '25Sale3.30499,8001,649,5400Mar 28 05:25 PM
DSS, INC.10% OwnerMar 26 '25Sale3.1358,139182,1341,099,481Mar 28 05:25 PM
DSS, INC.10% OwnerMar 27 '25Sale2.5047,681119,2551,051,800Mar 28 05:25 PM
DSS, INC.10% OwnerMar 20 '25Buy1.5520031053,280Mar 24 08:00 PM
DSS, INC.10% OwnerMar 20 '25Sale4.6853,280249,3500Mar 24 08:00 PM